Popular Articles

Nursing Shortage Eases With Recession's Help
"The nation"s deep recession is helping to alleviate the decade-long nursing shortage, as workers who had left the field in better times are returning in droves," the Wall Street Journal reports. The paper quotes a study, one of six papers on the nursing workforce published today in the journal Health Affairs, that found "nearly a quarter-million nurses entered the work force in 2007-08, an 18% surge that was the largest two-year increase in at least three decades." Many of them had left nursing, but "re-entered the work force to compensate for a spouse"s lost income or health benefits, the study said." The increase is "particularly remarkable at a time when the U.S. economy has shed more than six million jobs, helping to solidify the profession"s "recession-proof" image." The study found that the surge in new nurses is due to "efforts to expand nursing schools, attract more young people into the field and improve working conditions," along with an increase in the number of foreign-born nurses.

Upcoming BioAlliance Pharma's Presentations At International Conferences On Infectious Diseases And Oncology
BioAlliance Pharma SA (Paris:BIO), a company dedicated to therapies and supportive care for cancer and AIDS patients, announced its scientific communications at upcoming international conferences on infectious diseases and oncology:
News of the day
Bronx Campaign Boosts HIV Testing; Fauci Issues Statement Regarding National Testing Day
A three-year initiative launched last year by the New York City Department of Health and Mental Hygiene to test every adult in the Bronx for HIV has boosted testing by 28 percent, according to city health officials, the New York Times" blog "City Room" reports. The "Bronx Knows" campaign began with an effort to make voluntary HIV testing routine in emergency departments and clinics, where city officials said, "cumbersome consent procedures required by state law have deterred doctors from offering the tests," according to "City Room" (Chan, "City Room," New York Times, 6/24). The initiative - which involves clinics, hospitals and community organizations - tested nearly 160,000 Bronx residents in the past 12 months (United Press International, 6/24). The city also is participating in National HIV Testing Day on Saturday ("City Room," New York Times, 6/24).
Sexual Health

Pulmonary Hypertension Successfully Treated With Stem Cells

Zannos Grekos, MD, a featured speaker at the at the 17th Annual World Congress on Anti-Aging Medicine and Regenerative Biotechnologies, announced one year follow-up results for a pulmonary hypertension patient treated with his own activated stem cells. "It goes against traditional theory that we should try to fix the existing pulmonary vasculature, but we are generating new blood vessels with impressive results that are lasting beyond 12 months," said Grekos, assistant clinical professor of cardiology at Nova Southeastern University and head of the international team that developed the stem cell treatment protocol. According to Grekos, the clinical study is a collaborative effort among physicians at Regenocyte Therapeutic, a Florida-based stem cell clinic; researchers from TheraVitae, a biotechnology company in Tel Aviv, Israel; and physicians from Regenocyte"s Dominican Republic division. The patient"s base line and follow-up testing is being conducted in part by Mayo Clinic, Jacksonville, Florida. Patient Karl Wagner, 46 of Macon, Georgia, underwent the adult stem cell therapy in February 2008. Since being diagnosed with pulmonary hypertension, Wagner was on a rapid decline. "I was being managed by medication, but still had violent chest pains, heart palpitations, extreme fatigue, and severe shortness of breath. I could barely do anything with my daughters and was on oxygen almost all the time," said Wagner. "Doctors at Mayo Clinic gave me a three year prognosis." Grekos announced that at one year, the patient had maintained the benefits from his stem cell treatments. Wagner"s cardiac ultrasounds completed at the Mayo Clinic in Jacksonville showed a significant initial decrease of the pulmonary artery mean pressure from a pre-treatment high of 41mmHg (severe) to a post treatment low of 28mmHg (mild). Wagners pulmonary pressures remained at a low of 29mmHg even up to one year. The patient will continue to be monitored on a regular basis and it is expected that these numbers will remain low. This is extremely encouraging, and to-date, the other patients in the study are following the same pattern. "This is the first time medical science has successfully reversed the disease process in pulmonary hypertension, a previously untreatable condition with a very grim prognosis," Grekos explained. "Using advanced engineered stem cell technology and innovative delivery methods, we"ve been able to harness the regenerative power of stem cells and literally replace the damaged blood vessels in the lungs of the pulmonary hypertension patients." Wagner"s saturations are now consistently high and he no longer needs to be supplemented with oxygen or considered for a lung transplant. "I feel great," he says, "and have a normal life again. I take my girls to school every morning and work all day. My quality of life is ten-fold what it used to be. I also am off almost all of my medications and the doctors at Mayo Clinic have given me a new prognosis." Athina Kyritsis, MD, chair of Regenocyte"s Scientific Advisory Board, says the work announced today is based upon several years of Regenocyte"s clinical experience in the treatment of cardiac and vascular disease using autologous adult stem cell therapy. "In treating diseases like cardiomyopathy and peripheral vascular disease, we"ve had consistent success in generating viable heart tissue and growing new vessels. With the increased circulation, healing of wounds and improvement in ejection fractions, it seemed a natural progression to approach pulmonary hypertension in the same manner. I believe we have only begun to discover what adult stem cells can accomplish in altering the course of diseases now thought to be untreatable." Dr. Zannos Grekos will be hosting a free public seminar at the Sahib Shrine Center in Sarasota, Florida on May 30, 2009. Reservations can be made at http://www.regenocyte.com or by calling (866) 216-5710. Regenocyte Therapeutic


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):